Take the Incontinence Quiz Start the quiz
Skip to main content
Female with daughter dancing joyfully, in everyday home environment.

Urethral Bulking Agents for stress urinary incontinence

Speak to a specialist to see if this is a suitable treatment option for you.

Find a doctor

 Urethral Bulking for Stress Urinary Incontinence

Laugh, move and live with more confidence, discover a minimally invasive treatment option designed to help reduce bladder leakage and improve continence for women living with SUI. Speak with a specialist to learn whether urethral bulking may be a suitable treatment option for you.

What are urethral bulking agents?

Urethral Bulking Agent, which your doctor might refer to as UBAs are a minimally invasive, long-lasting treatment option for women with stress urinary incontinence.18  Stress incontinence occurs when urine leaks during daily activities such as coughing, sneezing, laughing or exercising. Urethral bulking aims to improve closure of the urethra to reduce leakage during physical movement.

Urethral bulking agents are injectable materials placed into the wall of the urethra, the tube that carries urine out of the bladder. The injections add volume to the urethral lining, which may provide greater support to help the urethra close during increases in abdominal pressure.

A female doctor in a white coat sits at a desk, smiling warmly as she speaks with a patient.

How does the procedure work?

Many women opt for urethral bulking as a treatment for their SUI because the procedure is minimally invasive. The procedure consists of 3-4 injections into the wall of the urethra, which maintains volume over time.

Typically, this procedure is performed in approximately 10-15 minutes under light sedation. There is a short recovery time along with less risk of serious complications.17 In one study, 56 of 67 women reported that they were able to resume normal daily activities within 24 hours.19

A specialist assessment is required to determine whether this procedure may be suitable for your symptoms.

Find a SUI specialist
woman laughing at lunch with friends

Who may be suitable for Urethral Bulking?

You may wish to consult a urologist or urogynecologist and discuss urethral bulking as a treatment option if you:

  • You have stress urinary incontinence
  • Pelvic floor physiotherapy has not sufficiently improved symptoms
  • You prefer a minimally invasive option
  • You are not seeking or suitable for more advanced surgery

References:

17. Dwyer et al., “Voice your choice”: A study of women’s choice for surgery for primary stress urinary incontinence, International Urogynecology Journal (2020), 31:769-777

18. Broshe T, et al., Seven year efficacy and safety outcomes of Bulkamid for the treatment of stress urinary incontinence, Journal of Neurology and Urodynamics, 2021;40:502-8

19. Bulkamid Patient Information Leaflet 2021 OUS 110-0256-003rB 06/2021

Disclaimer and endnotes: 

Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.

All images are the property of Boston Scientific. All trademarks are the property of their respective owners.

Individual symptoms, situations, circumstances and results may vary. This quiz is meant for information purposes only, it is not intended to be used for medical diagnosis or treatment or as a substitute for professional medical advice. Please consult your doctor or qualified healthcare provider regarding your condition and appropriate medical treatment. This site is intended for Australian residents only. Please review the Boston Scientific Privacy Policy, for practices on the collection, storage, use and disclosure of your personal information.

Content of videos are for Information Purposes only and does not constitute medical advice. BSC strongly recommends that you consult with your physician on all matters pertaining to your health or to address any questions.

The Axonics SNM system is not a first-line treatment. Surgery is required for use of Axonics SNM system, and any surgical procedure carries risk. Outcomes vary for each patient. Patients should consult their healthcare professional about factors that could impact response.

CAUTION: This product is not available for purchase by the general public. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com.

Australia and New Zealand: Boston Scientific Pty Ltd | PO Box 332 Botany NSW 1455 Australia